Annual FCF
-$59.66 M
-$4.20 M-7.57%
31 December 2023
Summary:
Lexeo Therapeutics Common Stock annual free cash flow is currently -$59.66 million, with the most recent change of -$4.20 million (-7.57%) on 31 December 2023. During the last 3 years, it has fallen by -$56.53 million (-1804.03%). LXEO annual FCF is now -1804.03% below its all-time high of -$3.13 million, reached on 01 December 2020.LXEO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$17.89 M
+$2.48 M+12.18%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock quarterly free cash flow is currently -$17.89 million, with the most recent change of +$2.48 million (+12.18%) on 30 September 2024. Over the past year, it has dropped by -$3.89 million (-27.76%). LXEO quarterly FCF is now -35.21% below its all-time high of -$13.23 million, reached on 30 June 2023.LXEO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$67.37 M
-$3.89 M-6.12%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock TTM free cash flow is currently -$67.37 million, with the most recent change of -$3.89 million (-6.12%) on 30 September 2024. Over the past year, it has dropped by -$21.77 million (-47.73%). LXEO TTM FCF is now -153.86% below its all-time high of -$26.54 million, reached on 30 June 2022.LXEO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXEO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.6% | -27.8% | -47.7% |
| 3 y3 years | -1804.0% | - | - |
| 5 y5 years | - | - | - |
LXEO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1804.0% | at low | -35.2% | +53.8% | -153.9% | +19.4% |
| 5 y | 5 years | -1804.0% | at low | -35.2% | +53.8% | -153.9% | +19.4% |
| alltime | all time | -1804.0% | at low | -35.2% | +53.8% | -153.9% | +19.4% |
Lexeo Therapeutics Common Stock Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.89 M(-12.2%) | -$67.37 M(+6.1%) |
| June 2024 | - | -$20.37 M(+35.3%) | -$63.49 M(+12.7%) |
| Mar 2024 | - | -$15.06 M(+7.2%) | -$56.35 M(-5.6%) |
| Dec 2023 | -$59.66 M | -$14.05 M(+0.4%) | -$59.66 M(+30.8%) |
| Sept 2023 | - | -$14.00 M(+5.8%) | -$45.61 M(-35.2%) |
| June 2023 | - | -$13.23 M(-28.0%) | -$70.33 M(-15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$18.37 M(-52.6%) | -$83.64 M(+28.2%) |
| Dec 2022 | -$55.46 M(+25.0%) | - | - |
| Sept 2022 | - | -$38.73 M(+45.9%) | -$65.27 M(+145.9%) |
| June 2022 | - | -$26.54 M | -$26.54 M |
| Dec 2021 | -$44.37 M(+1316.0%) | - | - |
| Dec 2020 | -$3.13 M | - | - |
FAQ
- What is Lexeo Therapeutics Common Stock annual free cash flow?
- What is the all time high annual FCF for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock annual FCF year-on-year change?
- What is Lexeo Therapeutics Common Stock quarterly free cash flow?
- What is the all time high quarterly FCF for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock quarterly FCF year-on-year change?
- What is Lexeo Therapeutics Common Stock TTM free cash flow?
- What is the all time high TTM FCF for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock TTM FCF year-on-year change?
What is Lexeo Therapeutics Common Stock annual free cash flow?
The current annual FCF of LXEO is -$59.66 M
What is the all time high annual FCF for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high annual free cash flow is -$3.13 M
What is Lexeo Therapeutics Common Stock annual FCF year-on-year change?
Over the past year, LXEO annual free cash flow has changed by -$4.20 M (-7.57%)
What is Lexeo Therapeutics Common Stock quarterly free cash flow?
The current quarterly FCF of LXEO is -$17.89 M
What is the all time high quarterly FCF for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high quarterly free cash flow is -$13.23 M
What is Lexeo Therapeutics Common Stock quarterly FCF year-on-year change?
Over the past year, LXEO quarterly free cash flow has changed by -$3.89 M (-27.76%)
What is Lexeo Therapeutics Common Stock TTM free cash flow?
The current TTM FCF of LXEO is -$67.37 M
What is the all time high TTM FCF for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high TTM free cash flow is -$26.54 M
What is Lexeo Therapeutics Common Stock TTM FCF year-on-year change?
Over the past year, LXEO TTM free cash flow has changed by -$21.77 M (-47.73%)